create a website

Why higher copayments for opioids did not reduce use among Medicare beneficiaries. (2024). Kaestner, Robert ; Joyce, Geoffrey ; Zhou, BO.
In: Health Economics.
RePEc:wly:hlthec:v:33:y:2024:i:3:p:466-481.

Full description at Econpapers || Download paper

Cited: 0

Citations received by this document

Cites: 23

References cited by this document

Cocites: 34

Documents which have cited the same bibliography

Coauthors: 0

Authors who have wrote about the same topic

Citations

Citations received by this document

    This document has not been cited yet.

References

References cited by this document

  1. Abaluck, J., Gruber, J., & Swanson, A. (2018). Prescription drug use under Medicare Part D: A linear model of nonlinear budget sets. Journal of Public Economics, 164, 106–138. https://doi.org/10.1016/j.jpubeco.2018.05.005.

  2. Alpert, A. E., Evans, W. N., Lieber, E. M. J., & Powell, D. (2019). Origins of the opioid crisis and its enduring impacts. National Bureau of Economic Research. No. w26500.

  3. Andraka‐Christou, B., Golan, O., Totaram, R., Ohama, M., Saloner, B., Gordon, A. J., & Stein, B. D. (2023). Prior authorization restrictions on medications for opioid use disorder: Trends in state laws from 2005 to 2019. Ann Med, 55(1), 514–520. https://doi.org/10.1080/07853890.2023.2171107.
    Paper not yet in RePEc: Add citation now
  4. Axeen, S. (2018). Trends in opioid use and prescribing in Medicare, 2006–2012. Health Services Research, 53, 5–3328. https://doi.org/10.1111/1475‐6773.12846.
    Paper not yet in RePEc: Add citation now
  5. Balestra, S., Liebert, H., Maestas, N., & Sherry, T. B. (2022).Behavioral responses to supply‐side drug policy during the opioid epidemic. CESifo Working Paper Series 9704.

  6. Buchmueller, T. C., & Carey, C. (2018). The effect of prescription drug monitoring programs on opioid utilization in Medicare. American Economic Journal: Economic Policy, 10(1), 77–112. https://doi.org/10.1257/pol.20160094.

  7. Centers for Disease Control and Prevention (Cdc) (2011). Vital signs: Overdoses of prescription opioid pain relievers‐‐‐United States, 1999‐‐2008. MMWR. Morbidity and Mortality Weekly Report, 60(43), 1487–1492.
    Paper not yet in RePEc: Add citation now
  8. Council of Economic Advisors (Cea), 2019. The role of opioid prices in the evolving opioid crisis. https://trumpwhitehouse.archives.gov/wp‐content/uploads/2019/04/The‐Role‐of‐Opioid‐Prices‐in‐the‐Evolving‐Opioid‐Crisis.pdf.
    Paper not yet in RePEc: Add citation now
  9. Economic report of the president, 2020. Chapter 7: Understanding the Opioid Crisis. Retrieved from https://www.govinfo.gov/app/collection/erp/2020.
    Paper not yet in RePEc: Add citation now
  10. Einav, L., Finkelstein, A., & Polyakova, M. (2018). Private provision of social insurance: Drug‐specific price elasticities and cost sharing in Medicare Part D. American Economic Journal: Economic Policy, 10(3), 122–153. https://doi.org/10.1257/pol.20160355.

  11. Food and Drug Administration (FDA) Analysis of long‐term trends in prescription opioid analgesic products: Quantity, Sales, and price trends, 2018. https://www.fda.gov/files/about%20fda/published/FDA‐Analysis‐of‐Long‐Term‐Trends‐in‐Prescription‐Opioid‐Analgesic‐Products‐‐Quantity‐‐Sales‐‐and‐Price‐Trends.pdf.
    Paper not yet in RePEc: Add citation now
  12. Gatewood, A. K., Van Wert, M. J., Andrada, A. P., & Surkan, P. J. (2016). Academic physicians' and medical students' perceived barriers toward bystander administered naloxone as an overdose prevention strategy. Addictive Behaviors, 61, 40–46. https://doi.org/10.1016/j.addbeh.2016.05.013.
    Paper not yet in RePEc: Add citation now
  13. Kaiser Family Foundation (KFF) (2017). Fact sheet: The Medicare Part D prescription drug benefit. https://www.kff.org/medicare/fact‐sheet/an‐overview‐of‐the‐medicare‐part‐d‐prescription‐drug‐benefit/.
    Paper not yet in RePEc: Add citation now
  14. Maclean, J. C., Mallatt, J., Ruhm, C. J., & Simon, K. (2020). Economic studies on the opioid crisis: A review.

  15. Meinhofer, A. (2016). The war on drugs: Estimating the effect of prescription. Drug Supply‐Side Interventions. https://doi.org/10.2139/ssrn.2716974.
    Paper not yet in RePEc: Add citation now
  16. Pacula, R. L., & Powell, D. (2018). A supply‐side perspective on the opioid crisis. Journal of Policy Analysis and Management, 37(2), 438–446. https://doi.org/10.1002/pam.22049.

  17. Ponnapalli, A., Grando, A., Murcko, A., & Wertheim, P. (2018). Systematic literature review of prescription drug monitoring programs. AMIA Annual Symposium Proceedings. Vol. 2018, p. 1478.
    Paper not yet in RePEc: Add citation now
  18. Samuels, E. A., Ross, J. S., & Dhruva, S. S. (2017). Medicare formulary coverage restrictions for prescription opioids, 2006 to 2015. Annals of Internal Medicine, 167(12), 895. https://doi.org/10.7326/M17‐1823.
    Paper not yet in RePEc: Add citation now
  19. Soni, A. (2018). Health insurance, price changes, and the demand for pain relief drugs: Evidence from Medicare Part D. Kelley School of Business Research Paper.
    Paper not yet in RePEc: Add citation now
  20. Van Nuys, K., Joyce, G., Ribero, R., & Goldman, D. P. (2018). Frequency and magnitude of co‐payments exceeding prescription drug costs. Jama, 319(10), 1045–1047. https://doi.org/10.1001/jama.2018.0102.
    Paper not yet in RePEc: Add citation now
  21. Volkow, N. D., McLellan, T. A., Cotto, J. H., Karithanom, M., & Weiss, S. R. (2011). Characteristics of opioid prescriptions in 2009. Jama, 305(13), 1299–1301. https://doi.org/10.1001/jama.2011.401.
    Paper not yet in RePEc: Add citation now
  22. Zhang, H., Tallavajhala, S., Kapadia, S. N., Jeng, P. J., Shi, Y., Wen, H., & Bao, Y. (2020). State opioid limits and volume of opioid prescriptions received by Medicaid patients. Med Care, 58(12), 1111–1115. PMID: 32925468; PMCID: PMC7808343. https://doi.org/10.1097/MLR.0000000000001411.
    Paper not yet in RePEc: Add citation now
  23. Zhou, C., Florence, C. S., & Dowell, D. (2016). Payments for opioids shifted substantially to public and private insurers while consumer spending declined, 1999–2012. Health Affairs, 35(5), 824–831. https://doi.org/10.1377/hlthaff.2015.1103.
    Paper not yet in RePEc: Add citation now

Cocites

Documents in RePEc which have cited the same bibliography

  1. Copayments for Prescription Drugs: The Drivers of Demand Responses. (2025). Verho, Jouko ; Harju, Jarkko.
    In: Health Economics.
    RePEc:wly:hlthec:v:34:y:2025:i:6:p:1160-1170.

    Full description at Econpapers || Download paper

  2. Patient cost-sharing and redistribution in health insurance. (2024). Klein, T J ; Upadhyay, S ; Salm, M.
    In: Health, Econometrics and Data Group (HEDG) Working Papers.
    RePEc:yor:hectdg:24/15.

    Full description at Econpapers || Download paper

  3. Why higher copayments for opioids did not reduce use among Medicare beneficiaries. (2024). Kaestner, Robert ; Joyce, Geoffrey ; Zhou, BO.
    In: Health Economics.
    RePEc:wly:hlthec:v:33:y:2024:i:3:p:466-481.

    Full description at Econpapers || Download paper

  4. Patient Cost-Sharing and Redistribution in Health Insurance. (2024). Klein, Tobias ; Upadhyay, Suraj ; Salm, Martin.
    In: IZA Discussion Papers.
    RePEc:iza:izadps:dp16778.

    Full description at Econpapers || Download paper

  5. No-claim refunds and healthcare use. (2024). Karlsson, Martin ; Avdic, Daniel ; Decker, Simon ; Salm, Martin.
    In: Journal of Public Economics.
    RePEc:eee:pubeco:v:230:y:2024:i:c:s0047272723002438.

    Full description at Econpapers || Download paper

  6. Hospital competition when patients learn through experience. (2024). Straume, Odd Rune ; Sa, Luis.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:97:y:2024:i:c:s0167629624000651.

    Full description at Econpapers || Download paper

  7. Pharmaceutical demand response to utilization management. (2024). Sarig, Oren.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:93:y:2024:i:c:s0167629623001078.

    Full description at Econpapers || Download paper

  8. Anticipated benefit termination and health care consumption responses: Evidence from a quasi-experiment. (2024). Yao, YI ; Wang, Yaojing ; Liu, Jiacheng.
    In: Journal of Economic Behavior & Organization.
    RePEc:eee:jeborg:v:227:y:2024:i:c:s0167268124003482.

    Full description at Econpapers || Download paper

  9. Identifying the impact of health insurance on subgroups with changing rates of diagnosis. (2023). Kaliski, Daniel.
    In: Health Economics.
    RePEc:wly:hlthec:v:32:y:2023:i:9:p:2098-2112.

    Full description at Econpapers || Download paper

  10. Moral Hazard in Drug Purchases. (2023). Verho, Jouko ; Harju, Jarkko.
    In: Working Papers.
    RePEc:fit:wpaper:12.

    Full description at Econpapers || Download paper

  11. Moral Hazard in Drug Purchases. (2023). Verho, Jouko ; Harju, Jarkko.
    In: CESifo Working Paper Series.
    RePEc:ces:ceswps:_10480.

    Full description at Econpapers || Download paper

  12. Present bias for monetary and dietary rewards. (2022). Tymula, Agnieszka ; Cheung, Stephen ; Wang, Xueting.
    In: Experimental Economics.
    RePEc:kap:expeco:v:25:y:2022:i:4:d:10.1007_s10683-022-09749-8.

    Full description at Econpapers || Download paper

  13. The response to dynamic incentives in insurance contracts with a deductible: Evidence from a differences-in-regression-discontinuities design. (2022). Klein, Tobias ; Upadhyay, Suraj ; Salm, Martin.
    In: Journal of Public Economics.
    RePEc:eee:pubeco:v:210:y:2022:i:c:s0047272722000627.

    Full description at Econpapers || Download paper

  14. Tiered cost sharing and health care demand. (2022). Ackley, Calvin A.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:85:y:2022:i:c:s0167629622000807.

    Full description at Econpapers || Download paper

  15. BE CAUTIOUS IN THE LAST MONTH: THE SUNK COST FALLACY HELD BY CAR INSURANCE POLICYHOLDERS. (2021). Ma, Chao.
    In: International Economic Review.
    RePEc:wly:iecrev:v:62:y:2021:i:3:p:1199-1236.

    Full description at Econpapers || Download paper

  16. Industrial Organization of Health Care Markets. (2021). Ho, Kate ; Handel, Benjamin R.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:29137.

    Full description at Econpapers || Download paper

  17. Quasi-Hyperbolic Present Bias: A Meta-Analysis. (2021). Tymula, Agnieszka ; Cheung, Stephen ; Wang, Xueting.
    In: IZA Discussion Papers.
    RePEc:iza:izadps:dp14625.

    Full description at Econpapers || Download paper

  18. Spot price biases in non-linear health insurance contracts. (2021). Skipper, Niels ; Simonsen, Marianne ; Christensen, Anne Illemann.
    In: Journal of Public Economics.
    RePEc:eee:pubeco:v:203:y:2021:i:c:s0047272721001444.

    Full description at Econpapers || Download paper

  19. Quality provision in hospital markets with demand inertia: The role of patient expectations. (2021). Straume, Odd Rune ; Sá, Luís ; Sa, Luis.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:80:y:2021:i:c:s0167629621001144.

    Full description at Econpapers || Download paper

  20. Does the framing of patient cost-sharing incentives matter? the effects of deductibles vs. no-claim refunds. (2021). Klein, Tobias ; Salm, Martin ; Hayen, Arthur P.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:80:y:2021:i:c:s0167629621001053.

    Full description at Econpapers || Download paper

  21. Disentangling moral hazard and adverse selection in private health insurance. (2021). Powell, David ; Goldman, Dana.
    In: Journal of Econometrics.
    RePEc:eee:econom:v:222:y:2021:i:1:p:141-160.

    Full description at Econpapers || Download paper

  22. Quality provision in hospital markets with demand inertia:The role of patient expectations. (2020). Straume, Odd Rune ; Sá, Luís.
    In: NIPE Working Papers.
    RePEc:nip:nipewp:03/2020.

    Full description at Econpapers || Download paper

  23. Insurance Design and Pharmaceutical Innovation. (2020). Agha, Leila ; Kim, Soomi ; Li, Danielle.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:27563.

    Full description at Econpapers || Download paper

  24. Liquidity Constraints and Demand for Healthcare: Evidence from Danish Welfare Recipients. (2020). Lyngse, Frederik Plesner.
    In: CEBI working paper series.
    RePEc:kud:kucebi:2028.

    Full description at Econpapers || Download paper

  25. The Response to Dynamic Incentives in Insurance Contracts with a Deductible: Evidence from a Differences-in-Regression-Discontinuities Design. (2020). Salm, Martin ; Klein, Tobias ; Upadhyay, Suraj.
    In: IZA Discussion Papers.
    RePEc:iza:izadps:dp13108.

    Full description at Econpapers || Download paper

  26. The elderlys response to a patient cost-sharing policy in health insurance: Evidence from China. (2020). Wang, Zhen ; Feng, Jin ; Song, Hong.
    In: Journal of Economic Behavior & Organization.
    RePEc:eee:jeborg:v:169:y:2020:i:c:p:189-207.

    Full description at Econpapers || Download paper

  27. The Response to Dynamic Incentives in Insurance Contracts with a Deductible: Evidence from a Differences-in-Regression-Discontinuities Design. (2020). Klein, Tobias ; Upadhyay, Suraj ; Salm, Martin.
    In: CEPR Discussion Papers.
    RePEc:cpr:ceprdp:14552.

    Full description at Econpapers || Download paper

  28. Liquidity Constraints and Demand for Healthcare: Evidence from Danish Welfare Recipients. (2020). Lyngse, Frederik Plesner.
    In: Papers.
    RePEc:arx:papers:2010.14651.

    Full description at Econpapers || Download paper

  29. Does the framing of patient cost-sharing incentives matter? The effects of deductibles vs. no-claim refunds. (2019). Salm, Martin ; Klein, Tobias ; Hayen, A P.
    In: Health, Econometrics and Data Group (HEDG) Working Papers.
    RePEc:yor:hectdg:19/12.

    Full description at Econpapers || Download paper

  30. How Do Couples Choose Individual Insurance Plans? Evidence from Medicare Part D. (2019). Sanguinetti, Tomas Pedro.
    In: 2019 Papers.
    RePEc:jmp:jm2019:psa1760.

    Full description at Econpapers || Download paper

  31. Non-Tariff Barriers and Bargaining in Generic Pharmaceuticals. (2019). McKibbin, Rebecca ; Ganapati, Sharat.
    In: Working Papers.
    RePEc:geo:guwopa:gueconwpa~18-18-23.

    Full description at Econpapers || Download paper

  32. Expenditure response to health insurance policies: Evidence from kinks in rural China. (2019). Shi, Julie ; Lu, Yi ; Yang, Wanyu.
    In: Journal of Public Economics.
    RePEc:eee:pubeco:v:178:y:2019:i:c:s0047272719301100.

    Full description at Econpapers || Download paper

  33. What to expect when you are expecting: Are health care consumers forward-looking?. (2019). Zhang, Jonathan ; Guo, Audrey.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:67:y:2019:i:c:s0167629618305289.

    Full description at Econpapers || Download paper

  34. Does the framing of patient cost-sharing incentives matter? The effects of deductibles vs. no-claim refunds. (2018). Salm, Martin ; Klein, Tobias ; Hayen, Arthur.
    In: CEPR Discussion Papers.
    RePEc:cpr:ceprdp:12908.

    Full description at Econpapers || Download paper

Coauthors

Authors registered in RePEc who have wrote about the same topic

Report date: 2025-09-22 23:35:26 || Missing content? Let us know

CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated August, 3 2024. Contact: Jose Manuel Barrueco.